Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats

British Journal of Pharmacology

Volumn 134, Issue 6, 2001, Pages 1227-1236

  Begon, Sophie ^a   Pickering, Gisèle ^a   Eschalier, Alain ^a   Mazur, André ^b   Rayssiguier, Yves ^b   Dubray, Claude ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CEMAGREF   (France)

Author keywords

Hyperalgesia; Magnesium; Magnesium deficient rats; NO; PKC; Spinal NMDA antagonists

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; CHELERYTHRINE; DIZOCILPINE; MAGNESIUM; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE; NOLPITANTIUM; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; HYPERALGESIA; MAGNESIUM DEFICIENCY; MALE; NOCICEPTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SPINAL CORD; TREATMENT OUTCOME;

EID: 0035199790     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704354     Document Type: Article

References (67)

1. Inhibition of rat cerebellar nitric oxide synthase by 7-Nitro indazole and related substituted indazoles
2. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain
3. 6,7-Dinitroquinoxaline-2,3-dion and 6-nitro, 7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor
4. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve evoked allodynia in the rat
5. Chemical changes in the cerebrospinal fluid and brain in magnesium deficiency
6. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats
7. Central neural mediators of secondary hyperalgesia following heat injury in rats: Neuropeptides and excitatory amino acids
8. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury
9. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests
10. Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviours
11. Effect of tachykinin receptor antagonists in experimental neuropathic pain
12. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy
13. Mechanisms of central hypersensitivity: Excitatory amino acid mechanisms and their control
14. Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat
15. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat
16. Magnesium deficiency induced an hyperalgesia reversed by the NMDA receptor antagonist MK-801
17. Sodium nitroprusside evoked the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms
18. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
19. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat
20. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat
21. The effect of intrathecal magnesium sulphate on nociception in rat acute pain models
22. The effect of intrathecal administration of magnesium sulphate in rats
23. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
24. Involvement of spinal protein kinase C in induction and maintenance of both persistent spontaneous flinching reflex and contralateral heat hyperalgesia induced by subcutaneous bee venom in the conscious rat
25. NMDA-receptor regulation of substance P release from primary afferent nociceptors
26. Mechanisms of blockade of excitatory amino acid receptor channels
27. Time course of inhibition of brain nitric oxide synthase by 7-Nitro indazole
28. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats
29. NMDA receptor activation modulates evoked release of substance P from rat spinal cord
30. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats
31. Inflammatory response following acute magnesium deficiency in rat
32. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy
33. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury
34. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviours in rats with experimental peripheral mononeuropathy
35. PKCγ contributes to a subset of the NMDA-dependent spinal circuits that underlie injury-induced persistent pain
36. Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons
37. Permeation and block of N-Methyl-D-Aspartic acid receptor channels by divalent cations in mouse cultured central neurones
38. Voltage-dependent block of magnesium of NMDA responses in spinal cord neurons
39. Nitric oxide (NO) and nociceptive processing in the spinal cord
40. Acute thermal hyperalgesia in the rat is produced by activation of N-Methyl-D-Aspartate receptors and protein kinase C and production of nitric oxide
41. A method to perform direct transcutenous intrathecal injection in rats
42. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits antinociceptive activity in the mouse without increasing blood pressure
43. Characterization of the novel nitric oxide synthase inhibitor 7-Nitro indazole and related indazoles: Antinociceptive and cardiovascular effects
44. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice
45. Magnesium gates glutamate-activated channels in mouse central neurons
46. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test
47. A method for measurement of analgesic activity on inflamed tissue
48. Central nervous system plasticity and persistent pain
49. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioural hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation
50. Increase spinal N-methylD-aspartate receptor function after 20 h of carrageenan-induced inflammation
51. Modulation of neuropathic pain behaviour in rats by spinal disinhibition and NMDA receptor blockage of injury discharge
52. The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation
53. Amplification of spinal nociceptive transmission depends on the generation of nitric oxide in normal and carrageenan rats
54. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurons in a rat model of mononeuropathy
55. Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation
56. NMDA evokes an L-NAME sensitive spinal release of glutamate and citrulline
57. Differential effects of MK-801, a N-methyl-D-aspartate non competitive antagonist, on the dorsal horn neurone hyperactivity and hyperexcitability in neuropathic rats
58. Anti-hyperalgesic effects of intrathecally administered magnesium sulfate in rats
59. Influence of pre-emptive treatment with MK-801, an N-methyl-D-aspartate receptor antagonist, on development of neuropathic symptoms induced by spinal nerve ligation in the rat
60. Clinical applications of excitatory amino acid antagonists in pain management
61. Transcriptional and post-translational plasticity and the generation of inflammatory pain
62. Magnesium suppresses neuropathic pain responses in rats via a spinal site of action
63. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. II. Excitatory amino acid antagonists
64. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK-801, an NMDA antagonist, on the formalin test in the rat
65. Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C
66. Reduction of voltage-dependent Mg2+ blockage of NMDA current in mechanically injured neurons
67. Ethical guidelines for investigations of experimental pain in conscious animals